Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Vandetanib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Caprelsa 100mg tablets
0801050BGBBAAAA
|
Caprelsa | Vandetanib | Malignant Disease and Immunosuppression | No data available |
|
Caprelsa 300mg tablets
0801050BGBBABAB
|
Caprelsa | Vandetanib | Malignant Disease and Immunosuppression | No data available |
|
Vandetanib 100mg tablets
0801050BGAAAAAA
|
Vandetanib | Vandetanib | Malignant Disease and Immunosuppression | No data available |
|
Vandetanib 300mg tablets
0801050BGAAABAB
|
Vandetanib | Vandetanib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.